2002 Results
Sort By:
Published on October 13, 2017
Inivata and Thermo Fisher Scientific are collaborating with Genomics England to assess the quality of blood plasma samples and explore the potential of liquid biopsy to improve disease management and patient outcomes. Thermo Fisher Scientific and Inivata will analyze about 500 plasma samples donated by participants in Genomics England’s 100,000…
Published on October 8, 2017
For you, why is a biomarker and diagnostic strategy so important and where is the most value gained from this approach? In Alzheimer’s disease (AD) drug development, over the past 15 years everything has failed. We finally understand and are targeting amyloid oligomers – the key pathogen of Alzheimer’s. Also,…
Published on October 3, 2017
Strata Oncology said today it will partner with University of California, San Francisco (UCSF), to expand access to tumor sequencing and clinical trials for men with metastatic prostate cancer. Strata, a precision oncology company, and UCSF are launching Stratify Prostate™, an initiative aimed at advancing precision medicine among men with…
Published on September 19, 2017
Cofactor Genomics has raised $18 million in Series A financing toward its next phase of growth, with plans to translate its RNA-based diagnostic platform into applications designed for research labs and clinical practices. Cofactor is commercializing a suite of clinical diagnostic assays targeting oncologic, immunologic, and neurodegenerative diseases. The company…
Published on September 13, 2017
GNS Healthcare and the Swedish Cancer Institute (SCI) said today they have launched a collaboration designed to help the cancer-care center strengthen, accelerate, and potentially expand its use of precision medicine in breast cancer care. GNS will use its Reverse Engineering and Forward Simulation (REFS™) causal machine learning and simulation…
Published on September 11, 2017
BioMarker Strategies said today it has won a two-year, $1.98 million Phase II Fast Track Small Business Innovation Research (SBIR) grant from the NIH’s National Cancer Institute (NCI) toward development of a companion diagnostic test toward facilitating therapy selection for patients with non-small cell lung cancer. PathMAP NSCLC is a…
Published on September 5, 2017
A study published today by researchers at Memorial Sloan Kettering Cancer Center (MSK) has concluded that simultaneous sequencing of tumor DNA and normal tissue for a broad panel of cancer-related genes may detect more potentially clinically significant heritable mutations than a targeted approach based on current clinical guidelines. The study…
Published on August 30, 2017
Extending noninvasive prenatal screening to all 24 human chromosomes can detect genetic disorders that may explain miscarriage and abnormalities during pregnancy, according to a study by researchers at the National Institutes of Health and other institutions. Because of the way data have been analyzed, typical genomic tests performed during pregnancy…
Published on August 30, 2017
A faster and easier approach to genetically reprogram cells, compared to current viral and electroporation methods is being explored by scientists based at the Fred Hutchinson Cancer Research Center. According to these scientists, nanoparticles can be used to deliver transient gene changes to targeted cells, making therapies for a variety…
Published on August 28, 2017
MedGenome said today it has completed a $30 million Series C financing, with the genomics research and diagnostics company directing proceeds toward its biomarker discovery programs and further development of its OncoPept™ suite of cancer immunotherapy biomarker solutions. The financing will allow genomic and biopharma researchers in the U.S. and…
Published on August 21, 2017
OmniSeq said today its Immune Report Card SM and OmniSeq ComprehensiveSM clinical assays will be distributed by LabCorp under an exclusive agreement whose value was not disclosed. LabCorp will also participate in the upcoming series B financing of OmniSeq, a subsidiary of the Roswell Park Cancer Institute in Buffalo, NY,…
Published on August 11, 2017
Beset with losses in the year since it went public, NantHealth plans to cut about one-third of its workforce—300 jobs—through layoffs and transfers of employees to one of its investors, Allscripts Healthcare Solutions, which will buy some of the company’s assets. NantHealth—a personalized healthcare company founded by Patrick Soon-Shiong, M.D.—did…
Published on August 2, 2017
The American Society of Clinical Oncology (ASCO) has weighed in on rising cancer drug prices, calling for healthcare stakeholders, members of Congress, and the Trump administration to work toward addressing affordability—including the development of a framework for assessing the value of treatments. The ASCO Position Statement On Addressing the Affordability…
Published on July 27, 2017
OneOme will offer pharmacogenomic testing through its RightMed platform exclusively to customers of ProZed Pharmacy Solutions, through a partnership that expands the precision medicine company into Canada’s retail pharmacy market. OneOme and ProZed have launched their Canada-wide partnership—whose value was not disclosed—at Northern Shores Pharmacy in North Bay, Ontario. ProZed's…
Published on July 26, 2017
The National Cancer Institute (NCI) and the Children’s Oncology Group (COG) have opened enrollment for a nationwide precision medicine trial for childhood cancers targeting solid tumors with specific genetic mutations. Dubbed Pediatric MATCH (Pediatric Molecular Analysis for Therapy Choice), the Phase 2 trial will comprise different drugs targeting specific sets…